We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Anchen Receives Tentative Approval For Generic Wellbutrin XL
Anchen Receives Tentative Approval For Generic Wellbutrin XL
November 29, 2005
Anchen Pharmaceuticals has received tentative approval from the FDA for its generic version of Biovail's extended-release antidepressant Wellbutrin XL (bupropion HCl) in 150- and 300-mg dosages.